Terizidone

This classification denotes an antitubercular agent with the molecular formula C14H14N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1199LEX5N8, chemically known as 4,4-(p-phenylenebis(methyleneamino))di-(isoxazolidin-3-one) but generally known as terizidone, which bears US NIH Compound Identifier 65720. European Medicines Agency schedules Terizidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15487MIG. The term TERIZIDONE is an International Non-Proprietary Name. World Health Organization schedules terizidone in its Anatomical Therapeutic Chemical (ATC) Classification. TERIZIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule terizidone under HS 29349990 and SITC 51579. As of Q4 2014, TERIZIDONE remains the US FDA Preferred Term for this commodity. Terizidone bears US NLM identifiers UMLS ID C0145184 and NCI Concept Code C90772. SMILES: O1NC(=O)C(/N=C/C2CCC(/C=N/C3CONC3=O)CC2)C1.